<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
	<title>Reporting Bias</title>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<meta name="description" content="" />
	<meta name="keywords" content="" />
	<meta name="robots" content="index,follow" />
	<link rel="stylesheet" type="text/css" href="/openmetaanalysis.css" />
<meta name="author" content="openMetaAnalysis Contributors">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<script src="//code.jquery.com/jquery.min.js"></script>
<style>
.wrapper
{
  width: 860px;
  margin-top: 0px;
  margin-right: auto;
  margin-bottom: 0px;
  margin-left: auto;
}
/* Menu from http://codepen.io/philhoyt/pen/ujHzd */
#primary_nav_wrap
{
	margin-top:15px;
}
#primary_nav_wrap ul
{
	list-style:none;
	position:relative;
	float:left;
	margin:0;
	padding:0
}
#primary_nav_wrap ul a
{
	display:block;
	background-color:#6DC6E7;
	color:#FFFFFF;
	text-decoration:none;
	font-weight:bold;
	//font-weight:700;
	//font-size:12px;
	line-height:32px;
	padding:0 15px;
	//font-family:"HelveticaNeue","Helvetica Neue",Helvetica,Arial,sans-serif
}
#primary_nav_wrap ul li
{
	position:relative;
	float:left;
	margin:0;
	padding:0
}
#primary_nav_wrap ul li.current-menu-item
{
	background:#0022B4;
		color:#FFFFFF;
}
#primary_nav_wrap ul a:hover
{
	background:#0022B4;
	color:#FFFFFF;
}
#primary_nav_wrap ul ul
{
	display:none;
	position:absolute;
	top:100%;
	left:0;
	background-color:#6DC6E7;
	color:#FFFFFF;
	padding:0
}
#primary_nav_wrap ul ul li
{
	float:none;
	width:200px
}
#primary_nav_wrap ul ul a
{
	line-height:120%;
	padding:10px 15px;
}
#primary_nav_wrap ul ul ul
{
	top:0;
	left:100%
}
#primary_nav_wrap ul li:hover > ul
{
	display:block
}
.supsub {position: relative; display: inline-block}
.superscript {display:block; position:relative; left:2px; top: -2px; line-height: 20%}
.subscript   {display:block; position:relative; left:2px; top:  4px; line-height: 20%}
</style>
</head>

<body>
<!-- 
http://jquery-csv.googlecode.com/git/examples/basic-usage.html
http://jquery-csv.googlecode.com/git/examples/flot.html -> seems best and most stable without reticulating splines error
http://code.google.com/p/jquery-csv/wiki/API -> instructions
-->
<div class="wrapper">

<div class="page-header">
      <div style="color:#0022B4">
		<h1>openMetaAnalysis: <span style="font-size:50%">collaborative and continuous</span></h1>
	</div>
	
<nav id="primary_nav_wrap">
<ul id="menu">
<li class="listitem"><a href="http://openmetaanalysis.github.io/" class="menuitem">Home</a></li>
<li class="listitem"><a href="#" class="menuitem">Plot editors</a>
	<ul>
	<li><a href="/opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor.html" class="menuitem">Intervention</a></li>
	<li><a href="/opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor.html#instruct" class="menuitem">Intervention (instructional)</a></li>
	<li><a href="/opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor-dx.html" class="menuitem">Diagnosis</a></li>
	<li class="listitem"><a href="https://openmetaanalysis.ocpu.io/home/www/arrows.html" class="menuitem">Arrows Plot</a></li>
	</ul>
</li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/methods.html" class="menuitem">Methods</a></li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/new.html" class="menuitem">Create a new review</a></li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/update.html" class="menuitem">Improve/update an existing review</a></li>
</ul>
</nav>
</div>
<div style="clear:both">&nbsp;</div>
    <div class="wrapper">
      <header>
  <h1 style="color:#0022B4">Reporting Bias</h1>
       </header>
      <section>

<div>This page provides the details underpinning an example of reporting bias. This example focuses on one clinical recommendation, topical NSAIDs versus placebo for non-back pain over 1-7 days, from a larger, very well-done clinical practice guideline (PMID <a href="http://pubmed.gov/32805126">32805126</a>).  The goal of this example is to demonstrate the need for authors of guidelines and evidence syntheses to provide rates that describe the possibility of publication bias their underlying evidence base:</div>
  <ul style="line-height:150%">
	  <li>Registration rate of published subjects (<b><i>p</i></b>Reg/Pub)
	    <ul><li><i>Prospective</i> registration rate of published subjects (Reg/Pub)</li></ul>
    </li>
    <li>Publication rate of registered subjects (Pub/Reg)</li>
  </ul>

<div>This example has been presented at the 2022 Annual Meeting of the Society of General Internal Medicine (see <a href="#notes">Notes</a> below).</div>

  <h2>Contents</h2>
  <ul>
    <li><a href="#section1">Registration rate (Rate Reg/Pub) of published subjects</a></li>
    <li><a href="#section2">Publication rate (Rate Pub/Reg) of subjects registered at ClinicalTrials.gov</a></li>
    <li><a href="#excluded">Excluded by APC from pairwise analysis but may be helpful</a></li>
  </ul>

<!-- **Edit here** -->

<h2 style="color:#0022B4" id="section1">Registration rate of published subjects</h2>
<h3>Summary</h3>
<table style="border:none">
	<tr><td style="width:50%;vertical-align:middle;border:none">
		<div>Numerator: total registered <i>and</i> published in 7 studies:</div>
			<ul><li>1316 = <span style='color:green;font-weight:bold'>314</span> + (<span style='color:blue;font-weight:bold'>770</span> + <span style='color:black;font-weight:bold'>232</span>) (font colors match colors in details below)</li></ul>
		<div>Denominator: total published in 27 studies (ACP Supplement Table 14 - pairwise analysis for pain at 1-7 days):</div>
			<ul><li>4777 subjects</li></ul>
		<div>Rate of registration of published subjects:</div>
			<ul><li>Rate Reg/Pub <span style='color:red'>28%</span> (1316/4777 subjects)</li></ul>
		<div>Rate of <i>prospective</i> registration of published subjects:</div>
			<ul><li><b>Rate pReg/Pub <span style='color:red'>2%</span></b> (<span style='color:orange;font-weight:bold'>72</span> /4777 subjects)</li></ul>
	</td><td style="width:50%;vertical-align:middle;border:none"><img src="https://openmetaanalysis.github.io/reporting-bias/Figure2a - 2023-06-07.png" width="600px" alt="Figure"/></td></tr>
</table>
<h3>ClinicalTrials.gov</h3>
	<div>Total registered <i>and</i> published in 2 studies: <span style='color:green;font-weight:bold'>314</span> = 242 + <span style='color:orange;font-weight:bold'>72</span> </div>
	<div>However, only the second study below (<span style='color:orange;font-weight:bold'>72</span> patients) was <i>registered at the time the study started</i>.</div>
	<!--
	<div>Total registered in 13 studies: 4101 subjects. The 13 includes 10 of the 11 trials listed as registered and ongoing at ClinicalTrials.gov in Appendix 2 of the ACP supplement plus 
		the two trials below (Lau, <a href="https://clinicaltrials.gov/ct2/show/NCT02324270">NCT02324270</a>, was found by the ACP and is one of the 11 included in Appendix 2. Lau's results were not posted at the time of the ACP publication).</div>
	-->
	<ul>
	<ul>1. Predel HG, Hamelsky S, Gold M, Giannetti B. Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Med Sci Sports Exerc. 2012 PMID <a href="http://pubmed.gov/22525762">22525762</a>. NCT00955513: <a href="https://clinicaltrials.gov/ct2/history/NCT00955513">Registration 08/2009</a> <span style='color:red;font-weight:bold'>(study started 06/2009)</span>; <a href="https://clinicaltrials.gov/ct2/show/results/NCT00955513">Results posted 01/2011</a>: 242 subjects</ul>
	<ul>2. Predel HG, Giannetti B, Pabst H, Schaefer A, Hug AM, Burnett I. Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled study. BMC Musculoskelet Disord. 2013 PMID <a href="http://pubmed.gov/23964752">23964752</a>. NCT01335724: <a href="https://clinicaltrials.gov/ct2/history/NCT01335724">Registration 04/2011</a> (study started 04/2011); <a href="https://clinicaltrials.gov/ct2/show/results/NCT01335724">Results 06/2012</a>: <span style='color:orange;font-weight:bold'>72</span> subjects<br/><br/></ul>
	</ul>

<h3>EU-CTR</h3>
	<div>Total registered <i>and</i> published in 4 studies: <span style='color:blue;font-weight:bold'>770</span> = 354+164+132+130</div>
	<div>However, the rate of prospective registration rate is not available at EU-CTR.</div>
	<ul>
	<ul>3. Hoffman P, Kopacka P, Gugliotta B, Rovati S. Efficacy and tolerability of DHEP-heparin plaster in reducing pain in mild-to-moderate muscle contusions: adouble-blind, randomized trial. Curr Med Res Opin. 2012 PMID <a href="http://pubmed.gov/22762346">22762346</a>. EU-CTR <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=2005-003829-31">2005-003829-31</a></ul>
	<ul>4. Predel HG, Pabst H, Schafer A, Voss D, Giordan N. Diclofenac patch for the treatment of acute pain caused by soft tissue injuries of limbs: a randomized, placebo-controlled clinical trial. JSports Med Phys Fitness. 2016;56(1-2):92-9. EU-CTR <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-020489-82">2005-003829-31</a></ul>
	<ul>5. Predel HG, Connolly MP, Bhatt A, Giannetti B. Efficacy and safety assessment of acute sports-related traumatic soft tissue injuries using a new ibuprofen medicated plaster: results from arandomized controlled clinical trial. Phys Sportsmed. 2017 PMID <a href="http://pubmed.gov/28926295">28926295</a>; EU-CTR <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-003257-29">2012-003257-29</a></ul>
	<ul>6. Predel HG, Giannetti B, Connolly MP, Lewis F, Bhatt A. Efficacy and tolerability of a new ibuprofen 200mg plaster inpatients with acute sports-related traumatic blunt soft tissue injury/contusion.Postgrad Med. 2018 PMID <a href="http://pubmed.gov/29110567">29110567</a>. EU-CTR <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-018018-21">2005-003829-31</a></ul>
	</ul>
<h3>Hungarian National Institute of Health registry</h3>
	<div>Total registered <i>and</i> published in 1 study: <span style='color:black;font-weight:bold'>232</span></div>
	<ul>
	<ul>7. Predel HG, Giannetti B, Seigfried B, Novellini R, Menke G. A randomized,double-blind, placebo-controlled multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel in the treatment of acute uncomplicated ankle sprain. J Int Med Res. 2013 PMID <a href="http://pubmed.gov/23908551">23908551</a>. Hungarian National Institute of Health registration 4526/40/98</ul>
	</ul>

<!-- Publication rate of subjects registered at ClinicalTrials.gov-->
<h2 style="color:#0022B4" id="section2">Publication rate of subjects registered at ClinicalTrials.gov</h2>
	      
<h3>Summary</h3>
<table style="border:none">
	<tr><td style="width:50%;vertical-align:middle;border:none">
		<div>Numerator: total published and registered in 2 studies:</div>
		<ul><li><span style='color:green;font-weight:bold'>314</span></li></ul>
		<div>Denominator: total registered in 13 studies:</div>
		<ul><li><!--4172 pre removing GSK and Lai-->3474 = <span style='color:black;font-weight:bold'>2889</span> + <span style='color:orange;font-weight:bold'>271</span> + <span style='color:green;font-weight:bold'>314</span></li></ul>
		<div>Publication rate of subjects registered at ClinicalTrials.gov:</div>
		<ul>
			<li><b>Rate Pub/Reg: <span style='color:red'>9%</span></b> (314/3474 subjects)</li>
		</ul>
	</td><td style="width:50%;vertical-align:middle;border:none"><img src="https://openmetaanalysis.github.io/reporting-bias/Figure2a - 2023-04-16.png" width="600px" alt="Figure"/></td></tr>
</table>
<!--
 	<div>Total published and registered in 2 studies: <span style='color:green;font-weight:bold'>314</span></div>
	<div>Total registered in 13 studies: (4172 pre removing GSK and Lai) 3474 = <span style='color:black;font-weight:bold'>2889</span> + <span style='color:green;font-weight:bold'>314</span> + <span style='color:black;font-weight:bold'>271</span></div>
	<div><b>Rate<span class='supsub'><sup class='superscript'>pub</sup><sub class='subscript'>reg</sub></span>: <span style='color:red">9%</span></b> (<span style='color:green;font-weight:bold'>314</span>/3474 subjects)</div>
-->
<h3>The CPG found 10 trials registered at ClinicalTrials.gov that were relevant but not published at the time of the ACP review (ACP Appendix 2)</h3>
<div>Subjects: <span style='color:black;font-weight:bold'>2889</span> (3202 [per studies in ACP Appendix 2] - 313 in GlaxoSmithKline)</div>
<div>Appendix 2 lists 11 trials, but this includes one trial that posted results after the ACP search that indicate the study design is not relevant to our question:</div>
<ul>
<ul>1. GlaxoSmithKline. Voltaren Emulgel 2% Acute Ankle Sprain Non-Inferiority Study. NCT04052620: <a href="https://clinicaltrials.gov/ct2/history/NCT04052620">Registration 2019</a> - <a href="https://clinicaltrials.gov/ct2/show/results/NCT04052620">Results 2022</a>: 313 subjects</ul>
</ul>

<div>The 10 relevant trials that remain include a trial that posted results 06/2020 <i>after</i> the ACP search of 12/2019:</div>
<a name="NCT02324270"/>
<ul>
<ul>2. Lau H. Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain. <span style='color:red;font-weight:bold'>PMID: NA (not published)</span>. NCT02324270: <a href="https://clinicaltrials.gov/ct2/history/NCT02324270">Registration 11/2014</a> <span style='color:red;font-weight:bold'>(study started 05/2014)</span>; <a href="https://clinicaltrials.gov/ct2/show/results/NCT02324270">Results 06/2020</a>: 647 subjects. <span style='color:red;font-weight:bold'>Results showed no benefit</span>.</ul>
</ul>

<div>Thus, 9 of the 10 relevant, unpublished trials that the the ACP indentifed at ClinicalTrials.gov are unaccounted for as of 09/04/2022. You can check the <a href="https://clinicaltrials.gov/ct2/results?cond=&term=NCT00903994+OR+NCT00869063+OR+NCT00869180+OR+NCT00680784+OR+NCT00680472+OR+NCT00765700+OR+NCT02089425+OR+NCT02695381+OR+NCT01874626">current status of these 9 studies</a>.</div>
	      
<h3>We found one additional registration with results posted but has not been published</h3>
<div>Subjects: <span style='color:orange;font-weight:bold'>271</span></div>
<a name="NCT00573768"/>
<ul><ul>3. Hamelsky S. Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain. <span style='color:red;font-weight:bold'>PMID: NA (not published)</span>. NCT00573768: <a href="<a href="https://clinicaltrials.gov/ct2/history/NCT00573768">Registration 12/2007</a> <span style='color:red;font-weight:bold'>(recruitment started 11/2007)</span>; <a href="https://clinicaltrials.gov/ct2/show/results/NCT00573768">Results 2010</a>: 271 subjects. <span style='color:red;font-weight:bold'>Results showed no benefit</span>.</ul>
</ul>
	      
<h3>The CPG found and included two additional trials that were both registered at ClinicalTrials.gov and published.</h3>
<div>Subjects: <span style='color:green;font-weight:bold'>314</span></div>
<a name="NCT00955513"/>
<ul>
	<ul>1. Predel HG, Hamelsky S, Gold M, Giannetti B. Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Med Sci Sports Exerc. 2012 PMID <a href="http://pubmed.gov/22525762">22525762</a>. NCT00955513: <a href="https://clinicaltrials.gov/ct2/history/NCT00955513">Registration 08/2009</a> <span style='color:red;font-weight:bold'>(study started 06/2009)</span>; <a href="https://clinicaltrials.gov/ct2/show/results/NCT00955513">Results posted 01/2011</a>: 242 subjects</ul>
	<ul><a name="NCT01335724"/>2. Predel HG, Giannetti B, Pabst H, Schaefer A, Hug AM, Burnett I. Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled study. BMC Musculoskelet Disord. 2013 PMID <a href="http://pubmed.gov/23964752">23964752</a>. NCT01335724: <a href="https://clinicaltrials.gov/ct2/history/NCT01335724">Registration 04/2011</a> (study started 04/2011); <a href="https://clinicaltrials.gov/ct2/show/results/NCT01335724">Results 06/2012</a>: 72 subjects<br/><br/></ul>
</ul>

<div>Note:</div>
<ul>
<li>The 314 subjects were in the 2 trials (8% of registered subjects) that were published showed benefit of NSAIDs (Predel, <a href="https://clinicaltrials.gov/ct2/show/NCT00955513">NCT00955513</a>; Predel, <a href="https://clinicaltrials.gov/ct2/show/NCT01335724">NCT01335724</a>).</li>
<li>Two trials that were registered but not published posted <span style='color:red;font-weight:bold'>Results showing no benefit</span> at ClinicalTrials.gov (Lau, 2014 <a href="https://clinicaltrials.gov/ct2/show/NCT02324270">NCT02324270</a>; Hamelsky, 2010 <a href="https://clinicaltrials.gov/ct2/show/NCT00573768">NCT00573768</a>)</li>
<li>The eleven registered trials without results were registered by industry between the years 2007 and 2019 (median year of registration 2009).</li>
</ul>


<h2 style="color:#0022B4" id="excluded">Excluded by APC from pairwise analyses but may be helpful</h2>
<ul>
<ul>1. Lai PM, Collaku A, Reed K. Efficacy and safety of topical diclofenac/menthol gel for ankle sprain: A randomized, double-blind, placebo- and active-controlled trial. J Int Med Res. 2017 PMID <a href="http://pubmed.gov/28345425">28345425</a>; <a href="https://clinicaltrials.gov/ct2/show/NCT02100670">NCT02100670</a>. NSAID not better than menthol, but ACP excluded as did not have true placebo.</ul>
<!-- Hid Serinken as actually there are other trials are excluded from our analysis due to shortness, but included in the ACP 15 minute to 2 hour analysis
<ul>2. Serinken M, Eken C, Elicabuk H. Topical Ketoprofen Versus Placebo in Treatment of Acute Ankle Sprain in the Emergency Department. Foot Ankle Int. 2016 PMID <a href="http://pubmed.gov/27198132">27198132</a>; <a href="https://clinicaltrials.gov/ct2/show/NCT02393846">NCT02393846</a>. NSAID superior at 30 minutes, but ACP excluded as did not report pain after 30 minutes.</ul> -->
</ul>

<h2  style="color:#0022B4" id="notes">Notes:</h2>
<div>This work was presented as a poster abstract at the 2022 Annual Meeting of the Society of General Internal Medicine:</div>
<div>&nbsp;</div>
<div>Badgett RG, Wissman K, Riaz IB, Bramley P, DeVito NJ. Can publication and selective reporting biases affect the recommendations of a well done clinical practice guideline? 2022 Annual Meeting of the Society of General Internal Medicine; 2022 April; Orlando, FL. J Gen Intern Med. 2022. doi: <a href="http://doi.org/10.1007/s11606-022-07653-8">10.1007/s11606-022-07653-8</a>. PMID: <a href="http://pubmed.gov/35713807">35713807</a>.</div>
</div>

<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
	
<!-- Edit above this line -->
</section>
       
      <footer>
        <p>This project is maintained by <a href="http://openmetaanalysis.github.io/">openMetaAnalysis</a></p>
        <p><small>Hosted on GitHub Pages &mdash; Theme by <a href="https://github.com/orderedlist">orderedlist</a></small></p>

<div id="business"></div>
      </footer>

</div>
    <script src="javascripts/scale.fix.js"></script>
              <script type="text/javascript">
            var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
            document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
          </script>
          <script type="text/javascript">
            try {
              var pageTracker = _gat._getTracker("UA-56740469-1");
            pageTracker._trackPageview();
            } catch(err) {}
          </script>
<div id="tip" style="display:none"></div>
</body>
</html>
